VOR
Vor Biopharma Inc
18.70$
+3.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -44.1% | +219.2% | +1.9% | -63.0% | +35.0% | +315.3% | +28.1% | -8.8% | -55.8% | +69.3% | -57.3% | +5.7% | -4.6% | +0.0% | -3.9% | -4.6% | +154.5% | – | – | +21.7% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +88.0% | +89.0% | +108.2% | -3.2% | +36.3% | +39.2% | -21.1% | +45.1% | -0.3% | -1.8% | +20.4% | +0.3% | +10.1% | +1.1% | +28.4% | +9.0% | +15.5% | -24.3% | +16.4% | -10.3% | 0.0% | +16.2% | +5.3% | +879.4% | -94.6% | +35.7% | -8.3% | +47.3% | – | |
| – | +0.0% | +288.8% | -55.1% | +77.1% | +21.0% | +76.4% | +18.9% | +10.5% | +13.0% | +4.9% | -1.1% | +34.0% | -14.1% | +11.9% | +6.0% | +11.0% | -2.7% | -6.9% | -6.3% | +10.8% | -9.9% | -7.2% | -10.9% | +10.5% | -63.6% | +501.4% | +16.3% | +4.6% | +25.1% | – | |
| – | +0.0% | +171.1% | +5.7% | +100.6% | +2.1% | +46.6% | +32.9% | -12.3% | +33.9% | +1.2% | -1.6% | +24.5% | -4.4% | +10.6% | +2.6% | +23.0% | +5.8% | +9.8% | -22.9% | +15.2% | -10.3% | +1.3% | +6.8% | +9.3% | +723.9% | -89.8% | +27.9% | -2.3% | +36.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +111.1% | +135.3% | +223.0% | +96.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -112.7% | – | – | |
| – | +0.0% | +33.4% | -93.1% | – | – | – | – | -100.7% | – | – | – | -100.1% | – | – | – | – | – | -53.5% | -60.3% | +59.2% | +0.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -112.7% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -112.7% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.